Intellectual Property Security Agreement

Recorded: 2009-03-02 Received: 2009-03-02 Pages: 13

Assignor

SYNVISTA THERAPEUTICS, INC.

Executed: 2009-02-24

Assignee

667 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10065, UNITED STATES

Covered Properties (8)

Use of Haptoglobin Genotyping in Diagnosis and Treatment of Cardiovascular Disease

Application: 12/276,963 →

Reagents and methods for detecting a polymorphic protein

Application: 61/129,250 →

Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)

Application: 12/153,186 →

PCT: PCTUS2008006162 ↗

Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individuals

Application: 12/071,270 →

Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype

Application: 11/798,488 →

Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic Patients

Application: 10/584,998 →

Methods of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hyperglycemic Patients

Application: 10/748,177 →

Method of Using Optically-Activated Particles in Cosmetic Preparations

Application: 10/095,669 →